Morgan Stanley Immatics N.V. Transaction History

Morgan Stanley

$1.36 Trillion
Q1 2025

A detailed history of Morgan Stanley transactions in Immatics N.V. stock. As of the latest transaction made, Morgan Stanley holds 3,093,614 shares of IMTX stock, worth $18.4 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

3,093,614

Previous 2,438,046 26.89%

Holding current value

$18.4 Million

Previous $17.3 Million 19.51%

% of portfolio

0.0%

Previous 0.0%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 15, 2025	BUY	$4.18 - $7.42 $2.74 Million - $4.86 Million	655,568 Added 26.89%	3,093,614 $14 Million
Q4 2024 Feb 14, 2025	BUY	$6.73 - $11.21 $15.3 Million - $25.5 Million	2,274,475 Added 1390.51%	2,438,046 $17.3 Million
Q3 2024 May 14, 2025	SELL	$10.93 - $12.92 $1.76 Million - $2.08 Million	-160,870 Reduced 49.58%	163,571 $1.87 Million
Q3 2024 Nov 14, 2024	SELL	$10.93 - $12.92 $1.76 Million - $2.08 Million	-160,870 Reduced 49.58%	163,571 $1.87 Million
Q2 2024 May 14, 2025	SELL	$9.78 - $13.49 $20.7 Million - $28.5 Million	-2,113,605 Reduced 86.69%	324,441 $3.77 Million
Q2 2024 Oct 17, 2024	SELL	$9.78 - $13.49 $1.84 Million - $2.54 Million	-188,456 Reduced 36.74%	324,441 $3.77 Million
Q2 2024 Aug 14, 2024	SELL	$9.78 - $13.49 $1.84 Million - $2.54 Million	-188,456 Reduced 36.74%	324,441 $3.77 Million
Q1 2024 Oct 17, 2024	BUY	$10.23 - $12.94 $1.93 Million - $2.44 Million	188,456 Added 58.09%	512,897 $5.39 Million
Q1 2024 Aug 16, 2024	BUY	$10.23 - $12.94 $3.68 Million - $4.65 Million	359,604 Added 234.59%	512,897 $5.39 Million
Q1 2024 May 15, 2024	BUY	$10.23 - $12.94 $3.68 Million - $4.65 Million	359,604 Added 234.59%	512,897 $5.39 Million
Q4 2023 Aug 16, 2024	SELL	$7.36 - $10.89 $1.26 Million - $1.86 Million	-171,148 Reduced 52.75%	153,293 $1.61 Million
Q4 2023 Feb 13, 2024	SELL	$7.36 - $10.89 $608,782 - $900,766	-82,715 Reduced 35.05%	153,293 $1.61 Million
Q3 2023 Nov 15, 2023	BUY	$11.01 - $12.62 $1.28 Million - $1.47 Million	116,688 Added 97.79%	236,008 $2.73 Million
Q2 2023 Aug 14, 2023	SELL	$5.92 - $12.72 $1.15 Million - $2.47 Million	-194,200 Reduced 61.94%	119,320 $1.38 Million
Q1 2023 May 15, 2023	BUY	$6.74 - $9.44 $488,791 - $684,598	72,521 Added 30.09%	313,520 $2.16 Million
Q4 2022 Feb 14, 2023	BUY	$8.05 - $11.58 $865,930 - $1.25 Million	107,569 Added 80.62%	240,999 $2.1 Million
Q3 2022 Nov 14, 2022	BUY	$3.31 - $13.06 $123,413 - $486,942	37,285 Added 38.78%	133,430 $1.34 Million
Q2 2022 Oct 27, 2022	BUY	$6.0 - $9.37 $303,048 - $473,259	50,508 Added 110.67%	96,145 $838,000
Q2 2022 Aug 15, 2022	BUY	$6.0 - $9.37 $303,048 - $473,259	50,508 Added 110.67%	96,145 $838,000
Q1 2022 Oct 27, 2022	SELL	$6.64 - $12.85 $335,373 - $649,027	-50,508 Reduced 52.53%	45,637 $365,000
Q1 2022 May 13, 2022	BUY	$6.64 - $12.85 $6,288 - $12,168	947 Added 2.12%	45,637 $365,000
Q4 2021 Feb 14, 2022	BUY	$10.81 - $14.38 $352,276 - $468,615	32,588 Added 269.28%	44,690 $600,000
Q3 2021 Nov 15, 2021	BUY	$11.58 - $15.46 $140,141 - $187,096	12,102 New	12,102 $157,000

Others Institutions Holding IMTX

# of Institutions

Shares Held

91.1M

Call Options Held

201K

Put Options Held

109K

View Full List

About Immatics N.V.

Ticker IMTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 76,227,000
Market Cap $453M
Description
Immatics N.V., a clinical-stage biopharmaceutical company, focuses on the discovery and development of T cell receptor (TCR) based immunotherapies for the treatment of cancer in the United States. The company is developing targeted immunotherapies with a focus on treating solid tumors through two distinct treatment modalities, such as adoptive c...

More about IMTX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Morgan Stanley, based on Form 13F filings with the SEC.

News

Stay updated on Morgan Stanley with notifications on news.

Account